This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignees: Korea Bone Bank, Inc., Cellumed Co., Ltd.. Active years: 2011-2016.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011-2016
Title: Young Bock Shim: Innovator in Tissue Engineering
Introduction
Young Bock Shim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of tissue engineering, particularly in the development of innovative methods for soft-tissue and bone graft substitutes. With a total of 3 patents, his work is paving the way for advancements in regenerative medicine.
Latest Patents
One of his latest patents is a method for manufacturing an allogeneic soft-tissue transplant that incorporates autologous stem cells. This method utilizes an allogeneic soft-tissue support obtained from another organism, allowing for the creation of a transplant that can effectively replace damaged soft tissue in humans. Another notable patent is for a cancellous bone graft substitute, which includes a method of manufacturing that employs supersonic cavitation. This innovative approach allows for rapid defatting, demineralizing, cleaning, and sterilizing processes without damaging the bone tissue, ensuring the physical properties of the graft substitute are maintained.
Career Highlights
Young Bock Shim has worked with notable companies such as Korea Bone Bank, Inc. and Cellumed Co., Ltd. His experience in these organizations has contributed to his expertise in the field of tissue engineering and regenerative medicine.
Collaborations
Some of his coworkers include Ju Woong Jang and Kwang Il Lee, who have collaborated with him on various projects related to his patents and innovations.
Conclusion
Young Bock Shim's contributions to tissue engineering through his innovative patents are significant. His work not only enhances the field of regenerative medicine but also offers hope for patients requiring soft-tissue and bone grafts.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile